Evidence map›Paper›PMID 35710638›Full record

ArticleIntensive care medicine experimental2022

Machine learning approaches to the human metabolome in sepsis identify metabolic links with survival.

Leah B Kosyakovsky, Emily Somerset, Angela J Rogers, Michael Sklar, Jared R Mayers, Augustin Toma, Yishay Szekely, Sabri Soussi, Bo Wang, Chun-Po S Fan and 2 more

Abstract read
In one paragraph

Article in Intensive care medicine experimental, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Leah B Kosyakovsky *Peter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Emily Somerset *Peter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Angela J RogersDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Michael SklarInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Jared R MayersDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
Augustin TomaDepartment of Medicine, University of Toronto, Toronto, Canada.
Yishay SzekelyPeter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Sabri SoussiInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Bo WangPeter Munk Cardiac Centre, University Health Network, Toronto, Canada.
Chun-Po S FanRogers Computational Program, Ted Rogers Centre for Heart Research, University of Toronto, Toronto, Canada.
Rebecca M BaronDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Patrick R LawlerPeter Munk Cardiac Centre, University Health Network, Toronto, Canada. patrick.lawler@uhn.ca.

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
The Inflammasome: A Novel Biomarker in ALI/ARDSR01HL112747 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI BARON, REBECCA M · 2012 to 2015
$1.8M
NHLBI NIH HHS R01 HL112747NHLBI NIH HHS T32 HL007633NIH HHS R01 HL112747-01
6 · The paper itself

Abstract

backgroundMetabolic predictors and potential mediators of survival in sepsis have been incompletely characterized. We examined whether machine learning (ML) tools applied to the human plasma metabolome could consistently identify and prioritize metabolites implicated in sepsis survivorship, and whether these methods improved upon conventional statistical approaches.

methodsPlasma gas chromatography-liquid chromatography mass spectrometry quantified 411 metabolites measured ≤ 72 h of ICU admission in 60 patients with sepsis at a single center (Brigham and Women's Hospital, Boston, USA). Seven ML approaches were trained to differentiate survivors from non-survivors. Model performance predicting 28 day mortality was assessed through internal cross-validation, and innate top-feature (metabolite) selection and rankings were compared across the 7 ML approaches and with conventional statistical methods (logistic regression). Metabolites were consensus ranked by a summary, ensemble ML ranking procedure weighing their contribution to mortality risk prediction across multiple ML models.

resultsMedian (IQR) patient age was 58 (47, 62) years, 45% were women, and median (IQR) SOFA score was 9 (6, 12). Mortality at 28 days was 42%. The models' specificity ranged from 0.619 to 0.821. Partial least squares regression-discriminant analysis and nearest shrunken centroids prioritized the greatest number of metabolites identified by at least one other method. Penalized logistic regression demonstrated top-feature results that were consistent with many ML methods. Across the plasma metabolome, the 13 metabolites with the strongest linkage to mortality defined through an ensemble ML importance score included lactate, bilirubin, kynurenine, glycochenodeoxycholate, phenylalanine, and others. Four of these top 13 metabolites (3-hydroxyisobutyrate, indoleacetate, fucose, and glycolithocholate sulfate) have not been previously associated with sepsis survival. Many of the prioritized metabolites are constituents of the tryptophan, pyruvate, phenylalanine, pentose phosphate, and bile acid pathways.

conclusionsWe identified metabolites linked with sepsis survival, some confirming prior observations, and others representing new associations. The application of ensemble ML feature-ranking tools to metabolomic data may represent a promising statistical platform to support biologic target discovery.

Indexed as

Artificial intelligenceMachine learningMetabolismMetabolomicsSepsis

Identifiers

PMID35710638
PMCPMC9203139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.